#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13678	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2160	628.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1423	1423	C	774	C	736	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24910	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3561	695.9	0	.	n	.	0	T695C	SNP	695	695	T	1082	1082	C	728	C	705	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24910	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3561	695.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1724	1724	A	805	A,C	772,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24910	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3561	695.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2358	2358	C	758	C	725	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24910	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3561	695.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2432	2432	A	742	A	718	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24910	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3561	695.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2984	2984	C	796	C	773	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1728	folP	852	852	100.0	folP.l15.c4.ctg.1	1405	121.7	1	SNP	p	R228S	1	.	.	682	684	AGC	979	981	AGC	158;159;158	A;G;C	154;156;154	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3970	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3564	110.9	1	SNP	p	S91F	0	.	.	271	273	TCC	691	693	TCC	154;153;156	T;C,T;C	148;149,1;153	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3970	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3564	110.9	1	SNP	p	D95G	0	.	.	283	285	GAC	703	705	GAC	159;158;159	G;A,C;C	154;152,1;155	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3970	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3564	110.9	1	SNP	p	D95N	0	.	.	283	285	GAC	703	705	GAC	159;158;159	G;A,C;C	154;152,1;155	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1526	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1373	110.6	1	SNP	p	G45D	1	.	.	133	135	GAC	476	478	GAC	197;195;198	G;A,C;C	195;188,1;195	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	812	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	960	84.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3860	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2994	128.2	1	SNP	p	D86N	0	.	.	256	258	GAC	594	596	GAC	150;150;152	G;A;C	148;146;148	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3860	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2994	128.2	1	SNP	p	S87I	0	.	.	259	261	AGT	597	599	AGT	154;152;152	A;G;T	149;148;145	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3860	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2994	128.2	1	SNP	p	S87W	0	.	.	259	261	AGT	597	599	AGT	154;152;152	A;G;T	149;148;145	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3860	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2994	128.2	1	SNP	p	S87R	0	.	.	259	261	AGT	597	599	AGT	154;152;152	A;G;T	149;148;145	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3860	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2994	128.2	1	SNP	p	S88P	0	.	.	262	264	TCC	600	602	TCC	154;156;157	T;C;C	149;152;152	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3730	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2455	150.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1461	1463	GGC	176;172;168	G;G;C	170;167;161	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3654	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2380	152.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1308	1310	GCA	153;155;156	G;C;A	147;150;151	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3654	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2380	152.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1311	1313	ATC	155;155;157	A;T;C	148;150;151	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3654	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2380	152.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1323	1325	GTG	165;161;159	G;T;G	158;157;155	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3654	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2380	152.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1323	1325	GTG	165;161;159	G;T;G	158;157;155	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3654	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2380	152.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1827	1829	ACC	181;182;184	A,C;C;C,A	167,1;174;174,2	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3654	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2380	152.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1881	1883	GCG	161;162;161	G;C,G;G	154;141,1;154	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3654	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2380	152.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1881	1883	GCG	161;162;161	G;C,G;G	154;141,1;154	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3654	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2380	152.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2004	2006	GGC	146;145;144	G;G;C	138;134;134	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3654	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2380	152.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2013	2015	GGC	139;135;133	G;G;C	128;128;124	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3654	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2380	152.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2031	2033	CCG	107;106;106	C,G;C;G	93,4;94;89	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	4560	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3126	144.9	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1678	1680	CTG	149;149;149	C;T;G	143;136;142	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.WHO_U_01087c	porA.WHO_U_01087c	1	0	539	828	porA	1188	1188	91.21	porA.l15.c4.ctg.1	1595	51.3	0	.	p	.	0	R34N	NONSYN	100	102	AGG	370	372	AAC	47;46;47	A;A;C	47;46;46	.	.
porA.WHO_U_01087c	porA.WHO_U_01087c	1	0	539	828	porA	1188	1188	91.21	porA.l15.c4.ctg.1	1595	51.3	0	.	p	.	0	A38L	NONSYN	112	114	GCG	382	384	CTG	48;48;49	C;T;G	48;48;49	.	.
porA.WHO_U_01087c	porA.WHO_U_01087c	1	0	539	828	porA	1188	1188	91.21	porA.l15.c4.ctg.1	1595	51.3	0	.	p	.	0	E42fs	FSHIFT	124	124	G	394	394	G	49	G	49	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2310	porB1b	1035	1035	98.57	porB1b.l15.c17.ctg.1	1540	149.3	0	.	p	.	0	V45I	NONSYN	133	135	GTT	482	484	ATT	165;166;163	A,G;T;T	157,1;158;154	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2310	porB1b	1035	1035	98.57	porB1b.l15.c17.ctg.1	1540	149.3	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	980	980	T	223	T	211	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2310	porB1b	1035	1035	98.57	porB1b.l15.c17.ctg.1	1540	149.3	1	SNP	p	G120K	0	.	.	358	360	GGT	707	709	GGT	171;171;171	G,A;G,A;T,C,G	164,1;167,1;157,2,2	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2310	porB1b	1035	1035	98.57	porB1b.l15.c17.ctg.1	1540	149.3	1	SNP	p	A121N	0	.	.	361	363	GCC	710	712	GCC	172;171;173	G,A;C,G,A;C	164,3;163,2,1;166	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2310	porB1b	1035	1035	98.57	porB1b.l15.c17.ctg.1	1540	149.3	1	SNP	p	A121D	0	.	.	361	363	GCC	710	712	GCC	172;171;173	G,A;C,G,A;C	164,3;163,2,1;166	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8218	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4796	170.3	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1974	1976	AAT	172;171;171	A;A;T	165;164;161	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	946	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1059	88.4	1	SNP	p	V57M	1	.	.	169	171	ATG	470	472	ATG	189;192;195	A;T;G	187;189;193	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
